Stockreport

TESARO's niraparib shows treatment effect in late-line ovarian cancer [Seeking Alpha]

TESARO  (TSRO) 
Last tesaro earnings: 11/1 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.tesarobio.com/investor-relations
PDF TESARO's niraparib shows treatment effect in late-line ovarian cancerTESARO (NASDAQ:TSRO)announces successful results from a late-stage study, QUADRA, evaluating ZEJULA [Read more]